Pathophysiology of Insulin Action in Humans

The Metabolic Syndrome at the Beginning of the XXI Century: A Genetic and Molecular Approach

Volumn , Issue , 2005, Pages 179-197

  del Prato, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747314517     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-84-8174-892-5.50011-5     Document Type: Chapter

References (181)

1. Ferrannini E, Galván AQ, Gastaldelli A, Camastra S, Sironi AM, Toschi E, Baldi S, Frascerra S, Monzani F, Antonelli A, Nanninpieri N, Mari A, Seghieri G, Natali A Insulin: new roles for an ancient hormone. Eur J Clin Invest 1999, 29:842-852.
2. Del Prato S, Ferrannini E, DeFronzo RA Evaluation of Insulin Sensitivity in Man. Methods in Diabetes Research 1986, Vol II:35-76. J. Wiley & Sons.
3. Himswhorth HPKR Insulin-sensitive and insulin-insensitive type of diabetes mellitus. Clin Sci 1938, 4:119-152.
4. Yalow RS, Berson SA Immunoassay of endogenous plasma insulin in man. Clin Invest 1960, 39:1157-1175.
5. Reaven GM Hypothesis: muscle insulin resistance is the («not so») thrifty genotype. Diabetologia 1988, 41:482-484.
6. Kahn CR Insulin resistance, insulin sensitivity, and insulin responsiveness: a necessary distinction. Metabolism 1978, 27:1893-1902.
7. Campbell PJ, Mandarino LJ, Gerich JE Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in noninsulin-dependent diabetes mellitus. Metabolism 1988, 37:15-21.
8. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, Winther K, Pedersen O Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 1996, 98:1195-1209.
9. Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M, Mykkanen L, Karter AJ, Hamman R, Saad MF Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 1997, 46:63-69.
10. Bergman RN Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989, 38:1512-1527.
11. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YD, Sands RE, Pei D, Savage PJ, Bergman RN A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 1994, 43:1114-1121.
12. Del Prato S, Maran A, Beck-Nielsen H The plurimetabolic sindrome in the European population: the experience of the European Group on Insulin Resistance (EGIR). Insulin resistance, Metabolic Diseases and Diabetic Complications 1999, 25-30. Elsevier Science B.V. G. Crepaldi, A. Tiengo, S. Del Prato (Eds.).
13. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Knowler WC, Bennett PH, Moll P, Bogardus C In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 1987, 36:1329-1335.
14. Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old danish twins. Diabetes 2005, 54:275-283.
15. Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 2003 Jul-Aug, 19(4):259-270.
16. Caprio S Insulin: the other anabolic hormone of puberty. Acta Paediatr Suppl 1999, 88:84-87.
17. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 1989, 84:205-213.
18. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981, 30:1000-1007.
19. DeFronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren J Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 1985, 76:149-155.
20. Roden M, Shulman GI Applications of NMR spectroscopy to study muscle glycogen metabolism in man. Annu Rev Med 1999, 50:277-290.
21. Williams KV, Bertoldo A, Mattioni B, Price JC, Cobelli C, Kelley DE Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model. J Clin Endocrinol Metab 2003, 88:1271-1279.
22. Hallsten K, Yki-Jarvinen H, Peltoniemi P, Oikonen V, Takala T, Kemppainen J, Laine H, Bergman J, Bolli GB, Knuuti J, Nuutila P Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese men. Obes Res 2003, 11:257-265.
23. Capaldo B, Lembo G, Napoli R, Rendina V, Albano G, Sacca L, Trimarco B Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism 1991, 40:1320-1322.
24. Natali A, Santoro D, Palombo C, Cerri M, Ghione S, Ferrannini E Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 1991, 17:170-178.
25. Bonadonna RC, Del Prato S, Bonora E, Gulli G, Solini A, DeFronzo RA Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose. Am J Physiol 1993, 265:E943-E953.
26. Bonadonna RC, Groop L, Kraemer N, Ferrannini E, Del Prato S, DeFronzo RA Obesity and insulin resistance in humans: a dose-response study. Metabolism 1990, 39:452-459.
27. Del Prato S, Enzi G, Vigili de Kreutzenberg S, Lisato G, Riccio A, Maifreni L, Iori E, Zurlo F, Sergi G, Tiengo A Insulin regulation of glucose and lipid metabolism in massive obesity. Diabetologia 1990, 33:228-236.
28. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S Insulin resistance in essential hypertension. N Engl J Med 1987, 317:350-357.
29. Del Prato S, Bonadonna RC, Bonora E, Gulli G, Solini A, Shank M, DeFronzo RA Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest 1993, 91:484-494.
30. Del Prato S, Vigili de Kreutzenberg S, Marescotti C, Dorella M, Da Tos V, Pipitone A, Bonadonna RC, Tiengo A Integrity of intracellular glucose metabolism and insulin resistance in non-diabetic obese subjects. Diabetologia 1994, 37(Suppl 1):A136.
31. Pirola L, Johnston AM, Van Obberghen E Modulation of insulin action. Diabetologia 2004, 47:170-184.
32. Shulman GI Cellular mechanisms of insulin resistance. J Clin Invest 2000, 106(2):171-176.
33. Bajaj M, DeFronzo RA Metabolic and molecular basis of insulin resistance. J Nucl Cardiol 2003 Jul, 10:311-323.
34. Andreelli F, Laville M, Ducluzeau PH, Vega N, Vallier P, Khalfallah Y, Riou JP, Vidal H Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients. Diabetologia 1999, 42:358-364.
35. Pratipanawatr W, Pratipanawatr T, Cusi K, Berria R, Adams JM, Jenkinson CP, Maezono K, DeFronzo RA, Mandarino LJ Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type [2] diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation. Diabetes 2001, 50:2572-2578.
36. Saccomani MP, Bonadonna RC, Bier DM, DeFronzo RA, Cobelli C A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study. Am J Physiol 1996, 270:E170-E185.
37. Kelley DE, Mintun MA, Watkins SC, Simoneau JA, Jadali F, Fredrickson A, Beattie J, Theriault R The effect of noninsulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 1996, 97:2705-2713.
38. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 1999, 341:240-246.
39. Bonadonna RC, Del Prato S, Saccomani MP, Bonora E, Gulli G, Ferrannini E, Bier D, Cobelli C, DeFronzo RA Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest 1993, 92:486-494.
40. Peltoniemi P, Lonnroth P, Laine H, Oikonen V, Tolvanen T, Gronroos T, Strindberg L, Knuuti J, Nuutila P Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans. Am J Physiol Endocrinol Metab 2000, 279:E1122-E1130.
41. Bonadonna RC, Del Prato S, Bonora E, Saccomani MP, Gulli G, Natali A, Frascerra S, Pecori N, Ferrannini E, Bier D, Cobelli C, DeFronzo RA Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 1996, 45:915-925.
42. Garvey WT, Maianu L, Hancock JA, Golichowski AM, Baron A Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 1992, 41:465-475.
43. Schalin-Jantti C, Yki-Jarvinen H, Koranyi L, Bourey R, Lindstrom J, Nikula-Ijas P, Franssila-Kallunki A, Groop LC Effect of insulin on GLUT-4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives. Diabetologia 1994, 37:401-407.
44. Zierath JR, He L, Guma A, Odegoard Wahlstrom E, Klip A Wallberg-Henriksson H. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 1996, 39:1180-1189.
45. Karnieli E, Armoni M Regulation of glucose transporters in diabetes. Horm Res 1990, 33:99-104.
46. Kruszynska YT, Mulford MI, Baloga J, Yu JG, Olefsky JM Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects. Diabetes 1998, 47:1107-1113.
47. Pendergrass M, Koval J, Vogt C, Yki-Jarvinen H, Iozzo P, Pipek R, Ardehali H, Printz R, Granner D, DeFronzo RA, Mandarino LJ Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. Diabetes 1998, 47:387-394.
48. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Deeb SS Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance. Diabetologia 1995, 38:617-622.
49. Petersen KF, Shulman GI Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 2002, 90:11G-18G.
50. Camastra S, Bonora E, Del Prato S, Rett K, Weck M, Ferrannini E Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance). Int J Obes Relat Metab Disord 1999, 23:1307-1313.
51. Petersen KF, Hendler R, Price T, Perseghin G, Rothman DL, Held N, Amatruda JM, Shulman GI 13C/31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes 1998, 47:381-386.
52. Bonora E, Targher G, Alberiche M, Bonadonna RC, Zenere MB, Saggiani F, Muggeo M Intracellular partition of plasma glucose disposal in hypertensive and normotensive subjects with type 2 diabetes mellitus. Clin Endocrinol Metab 2001, 86:2073-2079.
53. Bianchi S, Bigazzi R, Quiñones Galván A, Muscelli E, Baldari G, Pecori N, Ciociaro D, Ferrannini E, Natali A Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension 1995, 26:789-795.
54. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 1992, 41:1575-1586.
55. Rothman DL, Magnusson I, Cline G, Gerard D, Kahn CR, Shulman RG, Shulman GI Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1995, 92:983-987.
56. Vaag A, Henriksen JE, Beck-Nielsen H Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1992, 89:782-788.
57. Beck-Nielsen H, Vaag A, Poulsen P, Gaster M Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects-experiences from relatives and twin studies. Best Pract Res Clin Endocrinol Metab 2003, 17:445-467.
58. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990, 322:223-228.
59. Dent P, Lavoinne A, Nakielny S, Caudwell FB, Watt P, Cohen P The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 1990, 348:302-308.
60. Newgard CB, Brady MJ, O'Doherty RM, Saltiel AR Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1. Diabetes 2000, 49:1967-1977.
61. Freymond D, Bogardus C, Okubo M, Stone K, Mott D Impaired insulin-stimulated muscle glycogen synthase activation in vivo in man is related to low fasting glycogen synthase phosphatase activity. J Clin Invest 1988, 82:1503-1509.
62. Kida Y, Espósito-Del Puente A, Bogardus C, Mott DM Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. J Clin Invest 1990, 85:476-481.
63. Majer M, Mott DM, Mochizuki H, Rowles JC, Pedersen O, Knowler WC, Bogardus C, Prochazka M Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians. Diabetologia 1996, 39:314-321.
64. Chen YH, Hansen L, Chen MX, Bjorbaek C, Vestergaard H, Hansen T, Cohen PT, Pedersen O Sequence of the human glycogen-associated regulatory subunit of type 1 protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with NIDDM. Diabetes 1994, 43:1234-1241.
65. Prochazka M, Mochizuki H, Baier LJ, Cohen PT, Bogardus C Molecular linkage analysis of type-1 protein phosphatase catalytic beta-subunit gene: lack of evidence for its major role in insulin resistance in Pima Indians. Diabetologia 1995, 38:461-466.
66. Frame S, Cohen P GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001, 359:1-16.
67. Vestergaard H, Lund S, Larsen FS, Bjerrum OJ, Pedersen O Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1993, 91:2342-2350.
68. Kelley DE, Mokan M, Mandarino LJ Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 1992, 41:698-706.
69. Mandarino LJ, Consoli A, Jain A, Kelley DE Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol 1996, 270:E463-E470.
70. Thorburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 1990, 85:522-529.
71. Zawadzki JK, Wolfe RR, Mott DM, Lillioja S, Howard BV, Bogardus C Increased rate of Cori cycle in obese subjects with NIDDM and effect of weight reduction. Diabetes 1988, 37:154-159.
72. Avogaro A, Toffolo G, Miola M, Valerio A, Tiengo A, Cobelli C, Del Prato S Intracellular lactate- and pyruvateinterconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. J Clin Invest 1996, 98:108-115.
73. Randle PJ, Garland PB, Hales CN, Newsholme EA The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963, 1:785-789.
74. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989, 321:337-343.
75. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003, 100:8466-8471.
76. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003, 34:267-273.
77. Kelley DE, He J, Menshikova EV, Ritov VB Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51:2944-2950.
78. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004, 350:664-671.
79. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300:1140-1142.
80. Kelley DE, Goodpaster BH Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 2001, 24:933-941.
81. Nyholm B, Qu Z, Kaal A, Pedersen SB, Gravholt CH, Andersen JL, Saltin B, Schmitz O Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes 1997, 46:1822-1828.
82. Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, Nelson-Williams C, Raja KM, Kashgarian M, Shulman GI, Scheinman SJ, Lifton RP A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004, 306:1190-1194.
83. Kriketos AD, Pan DA, Lillioja S, Cooney GJ, Baur LA, Milner MR, Sutton JR, Jenkins AB, Bogardus C, Storlien LH Interrelationships between muscle morphology, insulin action, and adiposity. Am J Physiol 1996, 270:R1332-R1339.
84. Baron AD Hemodynamic actions of insulin. Am J Physiol 1994, 267:E187-202.
85. Zhang L, Vincent MA, Richards SM, Clerk LH, Rattigan S, Clark MG, Barrett EJ Insulin sensitivity of muscle capillary recruitment in vivo. Diabetes 2004, 53:447-453.
86. Serne EH, Gans RO, ter Maaten JC, ter Wee PM, Donker AJ, Stehouwer CD Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. Cardiovasc Res 2001, 49:161-168.
87. Bonadonna RC, Saccomani MP, Del Prato S, Bonora E, DeFronzo RA, Cobelli C Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle. Circulation 1998, 98:234-241.
88. Baron AD, Schaeffer L, Shragg P, Kolterman OG Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes 1987, 36:274-283.
89. Taylor R, Magnusson I, Rothman DL, Cline GW, Caumo A, Cobelli C, Shulman GI Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest 1996, 97:126-132.
90. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 1998, 102:619-624.
91. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, Landau BR, Ferrannini E Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 2000, 49:1367-1373.
92. Waldhausl W, Bratusch-Marrain P, Gasic S, Korn A, Nowotny P Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (noninsulin-dependent) diabetes mellitus. Diabetologia 1982, 23:6-15.
93. Del Prato S, Riccio A, Vigili de Kreutzenberg S, Dorella M, Tiengo A, DeFronzo RA Basal plasma insulin levels exert a qualitative but not quantitative effect on glucose-mediated glucose uptake. Am J Physiol 1995, 268:E1089-E1095.
94. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997, 46:1579-1585.
95. Bugianesi E, Zannoni C, Vanni E, Marzocchi R, Marchesini G Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?. Dig Liver Dis 2004, 36:165-173.
96. Boden G Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 2003, 111:121-124.
97. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999, 103:253-259.
98. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI Mechanism of free fatty acidinduced insulin resistance in humans. J Clin Invest 1996, 97:2859-2865.
99. De Kreutzenberg SV, Crepaldi C, Marchetto S, Calo L, Tiengo A, Del Prato S, Avogaro A Plasma free fatty acids and endothelium-dependent vasodilation: effect of chainlength and cyclooxygenase inhibition. J Clin Endocrinol Metab 2000, 85:793-798.
100. Steinberg HO, Baron AD Vascular function, insulin resistance and fatty acids. Diabetologia 2002, 45:623-634.
101. Williamson JR, Kreisberg RA, Felts PW Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA 1966, 56:247-254.
102. Bergman RN Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?. Diabetologia 2000, 43:946-952.
103. Ahima RS, Flier JS Leptin. Annu Rev Physiol 2000, 62:413-437.
104. Friedman JM, Halaas JL Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
105. Niswender KD, Schwartz MW Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol 2003, 24:1-10.
106. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002, 109:1345-1350.
107. Simha V, Szczepaniak LS, Wagner AJ, DePaoli AM, Garg A Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care 2003, 26:30-35.
108. Steppan CM, Lazar MA The current biology of resistin. J Intern Med 2004, 255:439-447.
109. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003, 300:472-476.
110. Wolf G Adiponectin: a regulator of energy homeostasis. Nutr Rev 2003, 61:290-292.
111. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Haring H, Stumvoll M Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003, 52:239-243.
112. Goldstein BJ, Scalia R Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004, 89:2563-2568.
113. Fasshauer M, Paschke R Regulation of adipocytokines and insulin resistance. Diabetologia 2003, 46:1594-1603.
114. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:E745-E751.
115. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001, 9:414-417.
116. Chiellini C, Santini F, Marsili A, Berti P, Bertacca A, Pelosini C, Scartabelli G, Pardini E, López-Soriano J, Centoni R, Ciccarone AM, Benzi L, Vitti P, Del Prato S, Pinchera A, Maffei M Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab 2004, 89:2678-2683.
117. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994, 91:4854-4858.
118. Hotamisligil GS, Spiegelman BM Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
119. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996, 45:881-885.
120. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, Chrousos GP Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 1997, 82:4167-4170.
121. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
122. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2004, 53:2473-2478.
123. Sparks JD, Sparks CE Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim Biophys Acta 1994, 1215:9-32.
124. Kendrick JS, Wilkinson J, Cartwright IJ, Lawrence S, Higgins JA Regulation of the assembly and secretion of very low density lipoproteins by the liver. Biol Chem 1998, 379:1033-1040.
125. Malmstrom R, Packard CJ, Watson TD, Rannikko S, Caslake M, Bedford D, Stewart P, Yki-Jarvinen H, Shepherd J, Taskinen MR Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 1997, 17:1454-1464.
126. Malmstrom R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Jarvinen H, Shepherd J, Taskinen MR Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes 1998, 47:779-787.
127. von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, Hamann A, Morcos M, Kreuzer J, Bierhaus A, Nawroth PP, Dugi KA Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care 2004, 27:2925-2929.
128. Annuzzi G, De Natale C, Iovine C, Patti L, Di Marino L, Coppola S, Del Prato S, Riccardi G, Rivellese AA Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 2004, 24:2397-2402.
129. Rivellese AA, De Natale C, Di Marino L, Patti L, Iovine C, Coppola S, Del Prato S, Riccardi G, Annuzzi G Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J Clin Endocrinol Metab 2004, 89:2153-2159.
130. Chan DC, Barrett PH, Watts GF Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modeling methods. Clin Sci (Lond) 2004, 107:233-249.
131. Carmena R, Duriez P, Fruchart JC Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004, 109(Suppl 1):III2-III7.
132. Skott P, Hother-Nielsen O, Bruun NE, Giese J, Nielsen MD, Beck-Nielsen H, Parving HH Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 1989, 32:694-699.
133. Natali A, Ferrannini E Hypertension, insulin resistance, and the metabolic syndrome. Endocrinol Metab Clin North Am 2004, 33:417-429.
134. Rocchini AP, Katch V, Kveselis D, Moorehead C, Martin M, Lampman R, Gregory M Insulin and renal sodium retention in obese adolescents. Hypertension 1989, 14:367-374.
135. Muscelli E, Natali A, Bianchi S, Bigazzi R, Galván AQ, Sironi AM, Frascerra S, Ciociaro D, Ferrannini E Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996, 9:746-752.
136. Rowe JW, Tobin JD, Rosa RM, Andrés R Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 1980, 29:498-502.
137. Helderman JH, Elahi D, Andersen DK, Raizes GS, Tobin JD, Shocken D, Andrés R Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 1983, 32:106-111.
138. Vincent MA, Montagnani M, Quon MJ Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep 2003, 3:279-288.
139. Hsueh WA, Law RE Insulin signaling in the arterial wall. Am J Cardiol 1999, 84:21J-24J.
140. Nickenig G, Bohm M Interaction between insulin and AT1 receptor. Relevance for hypertension and arteriosclerosis. Basic Res Cardiol 1998, 93(Suppl 2):135-139.
141. Hopfner RL, Hasnadka RV, McNeill JR, Wilson TW, Gopalakrishnan V Differential regulation of endothelin-1 action by insulin and vanadate in vascular smooth muscle. J Cardiovasc Pharmacol 1998, 31(Suppl 1):S196-S198.
142. Banfi C, Eriksson P, Giandomenico G, Mussoni L, Sironi L, Hamsten A, Tremoli E Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway. Diabetes 2001, 50:1522-1530.
143. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ Insulin resistance differentially affects the PI 3-kinaseand MAP kinase-mediated signaling in human muscle. J Clin Invest 2000, 105:311-320.
144. Montagnani M, Golovchenko I, Kim I, Koh GY, Goalstone ML, Mundhekar AN, Johansen M, Kucik DF, Quon MJ, Draznin B Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 2002, 277:1794-1799.
145. Grenett HE, Benza RL, Fless GM, Li XN, Davis GC, Booyse FM Genotype-specific transcriptional regulation of PAI-1 gene by insulin, hypertriglyceridemic VLDL, and Lp(a) in transfected, cultured human endothelial cells. Arterioscler Thromb Vasc Biol 1998, 18:1803-1809.
146. Trovati M, Anfossi G Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells. Diabetologia 1998, 41:609-622.
147. Baldi S, Natali A, Buzzigoli G, Galvan AQ, Sironi AM, Ferrannini E In vivo effect of insulin on intracellular calcium concentrations: relation to insulin resistance. Metabolism 1996, 45:1402-1407.
148. Scherrer U, Sartori C Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997, 96:4104-4113.
149. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981, 30:219-225.
150. Gans RO, Toorn L, Bilo HJ, Nauta JJ, Heine RJ, Donker AJ Renal and cardiovascular effects of exogenous insulin in healthy volunteers. Clin Sci (Lond) 1991, 80:219-225.
151. Young JB, Landsberg L Impaired suppression of sympathetic activity during fasting in the gold thioglucose-treated mouse. J Clin Invest 1980, 65:1086-1094.
152. Reaven GM, Lithell H, Landsberg L Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334:374-381.
153. Schulingkamp RJ, Pagano TC, Hung D, Raffa RB Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 2000, 4:855-872.
154. Zhao WQ, Chen H, Quon MJ, Alkon DL Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol 2004, 490:71-81.
155. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004, 292:2237-2242.
156. Hendrickx H, Lane J, Coverrly J, Simcox J, Stocks J, Brown L Declarative and working memory deficits in middleaged, insulin resistant men. Diabetologia 2004, 47(Suppl 1):A237.
157. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289:2122-2125.
158. Lin X, Taguchi A, Park S, Kushner JA, Li F, Li Y, White MF Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 2004, 114:908-916.
159. Del Prato S, Wishner WJ, Gromada J, Schluchter BJ Betacell mass plasticity in type 2 diabetes. Diabetes Obes Metab 2004, 6:319-331.
160. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999, 96:329-339.
161. Kulkarni RN, Winnay JN, Daniels M, Bruning JC, Flier SN, Hanahan D, Kahn CR Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J Clin Invest 1999, 104:R69-75.
162. Withers DJ, Gutiérrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998, 391:900-904.
163. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 2001, 7:1133-1137.
164. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 2001, 108:1631-1638.
165. Accili D A kinase in the life of the beta cell. J Clin Invest 2001, 108:1575-1576.
166. Hribal ML, Federici M, Porzio O, Lauro D, Borboni P, Accili D, Lauro R, Sesti G The Gly→Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocrinol Metab 2000, 85:2004-2013.
167. Clausen JO, Hansen T, Bjorbaek C, Echwald SM, Urhammer SA, Rasmussen S, Andersen CB, Hansen L, Almind K, Winther K., et al. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 1995, 346:397-402.
168. Armstrong M, Haldane F, Avery PJ, Mitcheson J, Stewart MW, Turnbull DM, Walker M Relationship between insulin sensitivity and insulin receptor substrate-1 mutations in non-diabetic relatives of NIDDM families. Diabet Med 1996, 13:341.
169. Marchetti P, Lupi R, Federici M, Marselli L, Masini M, Boggi U, Del Guerra S, Patane G, Piro S, Anello M, Bergamini E, Purrello F, Lauro R, Mosca F, Sesti G, Del Prato S Diabetes 2002, 51:1419-1424.
170. Lupi R, Del Guerra S, Marselli L, Bugliani M, Boggi U, Mosca F, Marchetti P, Del Prato S Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab 2004, 286:E560-E567.
171. Marchetti P, Del Guerra S, Marselli L, Lupi R, Masini M, Pollera M, Bugliani M, Boggi U, Vistoli F, Mosca F, Del Prato S Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004, 89:5535-5541.
172. Sahu A Minireview: A hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 2004, 145:2613-2620.
173. Figlewicz DP Adiposity signals and food reward: expanding the CNS roles of insulin and leptin. Am J Physiol Regul Integr Comp Physiol 2003, 284:R882-R892.
174. Marques-Lopes I, Forga L, Martínez JA Thermogenesis induced by a high-carbohydrate meal in fasted lean and overweight young men: insulin, body fat, and sympathetic nervous system involvement. Nutrition 2003, 19:25-29.
175. Landsberg L Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 2001, 19:523-528.
176. Storlien L, Oakes ND, Kelley DE Metabolic flexibility. Proc Nutr Soc 2004, 63:363-368.
177. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Jarvinen H Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 1997, 30:1144-1149.
178. Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E, Bonadonna RC Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002, 105:576-582.
179. Ceolotto G, Bevilacqua M, Papparella I, Baritono E, Franco L, Corvaja C, Mazzoni M, Semplicini A, Avogaro A Insulin generates free radicals by an NAD(P)H, phosphatidylinositol 3'-kinase-dependent mechanism in human skin fibroblasts ex vivo. Diabetes 2004, 53:1344-1351.
180. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994, 37:1025-1035.
181. Nawrocki AR, Scherer PE The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation. Curr Opin Pharmacol 2004, 4:281-289.